Mon, 17th May 2021 10:22
NEW DELHI, May 17 (Reuters) - An Indian government panel has
found 26 potential cases of bleeding and clotting after
administration of AstraZeneca Plc's Covishield vaccine,
the health ministry said on Monday.
"There is a very miniscule but definitive risk of
thromboembolic events" after being vaccinated, the data showed.
(Reporting by Krishna N. Das, writing by Tanvi Mehta
Editing by Gareth Jones)
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:
(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...
(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...
June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...
Astrazeneca (AZN)